Phloroglucinol Effectiveness on Shortening the Duration of Active Phase of Labor
NCT ID: NCT07184099
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
134 participants
INTERVENTIONAL
2025-01-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Compare Sweeping of Membranes Versus Expectant Management for Spontaneous Onset of Labor and Vaginal Delivery.
NCT06949787
Early V/S Delayed Induction of Labour in Patients With Prelabour Rupture of Membranes
NCT07261332
The Effect of Entonox on Stages of Labor in Nulliparous Women
NCT04321642
Foley Catheter Versus PGE2 for Labor Induction at Term: a Pilot Study
NCT04780269
A Comparison Between the Effect of Oxytocin Only and Oxytocin Plus Propranolol on Induction of Labor in Term Pregnancy
NCT03533699
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phloroglucinol group
Phloroglucinol was administered as intravenous stat infusion with Ringer Lactate infusion.
Phloroglucinol
Phloroglucinol was administered as intravenous stat infusion with Ringer Lactate infusion.
Placebo group
The patients were given only Ringer Lactate infusion.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phloroglucinol
Phloroglucinol was administered as intravenous stat infusion with Ringer Lactate infusion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Period of gestation above 37 weeks.
Exclusion Criteria
* Double scare uterus
* Fetal distress
* Life threatening bleeding
* Eclampsia
* History of heart disease
* Known allergy to phloroglucinol
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muhammad Aamir Latif
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Aamir Latif
Research Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tahira Riaz, FCPS
Role: PRINCIPAL_INVESTIGATOR
Combined military hospital Attock
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Combined Military Hospital
Attock, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dr-Tahira-Attock
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.